MS prevalence has increased by about one-third in New Zealand in recent decades, though some barriers to diagnosis still ...

People with MS who experience chronic lower body pain have altered gait patterns, walking more slowly than those without this ...

Columnist Desiree Lama explains the sometimes confusing experience of living with MS and anxiety that hits her every morning.

After years of hiding her MS, a New York woman now is racing toward acceptance – riding her handcycle in three races – and to ...

Pro-inflammatory signaling molecules in MS cause problems with the growth and development of myelin-making cells in the brain ...

Children with pediatric-onset MS tend to use more healthcare resources, starting from birth and escalating until their ...

As aging has her experiencing estrogen loss and her MS, columnist Susan Payrovi evaluates her response to the changes she's ...

Using disease-modifying therapies in MS tends to reduce the risk of stroke, though effects vary depending on the type of DMT, ...

Alvotech is expanding its partnership with Advanz Pharma to commercialize new products in Europe, including a Kesimpta biosimilar drug for MS.

Columnist Desiree Lama writes in praise of community and human connections, which make such a difference when living with multiple sclerosis.

MS patients on B-cell depleting therapies are still protected against COVID-19 risk due to greater anti-viral T-cell activity, a study found.